Literature DB >> 10952784

Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.

D A Tonetti1, M J Chisamore, W Grdina, H Schurz, V C Jordan.   

Abstract

An inverse relationship between protein kinase C (PKC) activity and oestrogen receptor (ER) expression in human breast cell lines and tumours has been firmly established over the past 10 years. To determine whether specific alterations in PKC expression accompany hormone-independence, we examined the expression of PKC isozymes in the hormone-independent human breast cancer cell clones MCF-7 5C and T47D:C42 compared with their hormone-dependent counterparts, MCF-7 A4, MCF-7 WS8 and T47D:A18 respectively. Both hormone-independent cell clones exhibit elevated PKC alpha expression and increased basal AP-1 activity compared with the hormone-dependent cell clones. To determine whether PKC alpha overexpression is sufficient to mediate the hormone-independent phenotype, we stably transfected an expression plasmid containing PKC alpha cDNA to the T47D:A18 and MCF-7 A4 cell lines. This is the first report of PKC alpha transfection in T47D cells. In contrast to MCF-7 cells, T47D has the propensity to lose the ER and more readily forms tamoxifen-stimulated tumours in athymic mice. We find that in T47D:A18/PKC alpha clones, there is concomitant up-regulation of PKC beta I and delta, whereas in the MCF-7 A4/PKC alpha transfectants PKC epsilon is up-regulated. In T47D:A18, but not in MCF-7 A4, PKC alpha stable transfection is accompanied by down-regulation of ER function whilst basal AP-1 activity is elevated. Our results suggest PKC alpha overexpression may play a role in growth signalling during the shift from hormone dependent to hormone-independent breast cancers. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952784      PMCID: PMC2363523          DOI: 10.1054/bjoc.2000.1326

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  43 in total

1.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

2.  Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors.

Authors:  C Borner; R Wyss; R Regazzi; U Eppenberger; D Fabbro
Journal:  Int J Cancer       Date:  1987-09-15       Impact factor: 7.396

3.  Luciferase reporter gene vectors for analysis of promoters and enhancers.

Authors:  S K Nordeen
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

4.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

6.  cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.

Authors:  L M Smith; S C Wise; D T Hendricks; A L Sabichi; T Bos; P Reddy; P H Brown; M J Birrer
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

7.  Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue.

Authors:  C O'Brian; V G Vogel; S E Singletary; N E Ward
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

8.  Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.

Authors:  J A Dumont; A J Bitonti; C D Wallace; R J Baumann; E A Cashman; D E Cross-Doersen
Journal:  Cell Growth Differ       Date:  1996-03

9.  Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  M Saceda; C Knabbe; R B Dickson; M E Lippman; D Bronzert; R K Lindsey; M M Gottardis; M B Martin
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

10.  Phorbol ester and epidermal growth factor receptors in human breast cancer.

Authors:  R Wyss; D Fabbro; R Regazzi; C Borner; A Takahashi; U Eppenberger
Journal:  Anticancer Res       Date:  1987 Jul-Aug       Impact factor: 2.480

View more
  26 in total

1.  Protein kinase Cα mediates erlotinib resistance in lung cancer cells.

Authors:  Mahlet B Abera; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2015-02-27       Impact factor: 4.436

Review 2.  Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.

Authors:  Jennifer R Ribeiro; Richard N Freiman
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-22       Impact factor: 4.292

3.  Protein kinase Cα suppresses the expression of STC1 in MDA-MB-231 breast cancer cells.

Authors:  Louise Cornmark; Gry Kalstad Lønne; Annika Jögi; Christer Larsson
Journal:  Tumour Biol       Date:  2011-07-01

Review 4.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

Review 5.  The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-10-22       Impact factor: 5.678

6.  Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).

Authors:  Jiawang Liu; Shilong Zheng; Victoria L Akerstrom; Chester Yuan; Youning Ma; Qiu Zhong; Changde Zhang; Qiang Zhang; Shanchun Guo; Peng Ma; Elena V Skripnikova; Melyssa R Bratton; Antonio Pannuti; Lucio Miele; Thomas E Wiese; Guangdi Wang
Journal:  J Med Chem       Date:  2016-08-29       Impact factor: 7.446

7.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

8.  PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.

Authors:  Karine Belguise; Gail E Sonenshein
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure.

Authors:  D A Tonetti; M Morrow; N Kidwai; A Gupta; S Badve
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

Review 10.  Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

Authors:  Joan S Lewis-Wambi; V Craig Jordan
Journal:  Breast Cancer Res       Date:  2009-05-29       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.